Rapport TherapeuticsRAPP
13F holders, Q3 2024 (September 30)55holders +20
27new positions
10sold out
1famous investor
$20.46avg. 13F price*
At the end of Q3 2024, 55 institutions reported holding Rapport Therapeutics Inc. (RAPP) in their 13F filings, up 20 from Q2 2024. 27 opened new positions and 10 sold out. The largest holders were FMR LLC ($112.4M), ARCH Venture Management, LLC ($76.4M) and Cormorant Asset Management, LP ($60.2M). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Rapport Therapeutics Inc.
- CUSIP
- 75383L102
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 27 | $37.8M |
| Exits | 10 | $16.1M |
All 13F filers, Q2 2024 → Q3 2024: 3,107,909 shares bought and 1,182,718 shares sold, net +1,925,191 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 55 holders
| FMR LLC | 0.01% | Add +10.1% | 5,486,468 | $112.4M |
| ARCH Venture Management, LLC | 29.31% | No change | 3,728,738 | $76.4M |
| Cormorant Asset Management, LP | 3.19% | Add +0.0% | 2,940,921 | $60.2M |
| Capital International Investors | 0.01% | Reduce 0.0% | 2,602,529 | $53.3M |
| Johnson & Johnson | 11.97% | No change | 2,498,051 | $51.2M |
| Sofinnova Investments, Inc. | 3.38% | Add +2.3% | 1,995,594 | $40.9M |
| T. Rowe Price Investment Management, Inc. | 0.02% | Add +12.5% | 1,727,111 | $35.4M |
| Goldman Sachs Group Inc. | 0.00% | New | 1,247,171 | $25.5M |
| Alliancebernstein L.P. | 0.01% | Reduce -0.2% | 1,088,921 | $22.3M |
| T. Rowe Price Associates Inc. | 0.00% | Reduce -23.0% | 1,047,408 | $21.5M |
| Perceptive Advisors LLC | 0.33% | No change | 748,183 | $15.3M |
| BlackRock, Inc. | 0.00% | — | 576,118 | $11.8M |
| Vanguard Group Inc. | 0.00% | Add +624.0% | 506,767 | $10.4M |
| Citadel Advisors | 0.01% | Reduce -17.7% | 487,458 | $9.5M |
| Siren, L.L.C. | 0.39% | — | 384,197 | $7.9M |
| Geode Capital Management, LLC | 0.00% | New | 201,748 | $4.1M |
| Logos Global Management LP | 0.46% | No change | 208,910 | $4.1M |
| Woodline Partners LP | 0.03% | Add +9.0% | 186,560 | $3.8M |
| Eventide Asset Management, LLC | 0.04% | Add +120.8% | 110,401 | $2.3M |
| Manufacturers Life Insurance Company, The | 0.00% | Add +2.4% | 77,344 | $1.6M |
| Charles Schwab Investment Management Inc. | 0.00% | New | 73,146 | $1.5M |
| Northern Trust Corp. | 0.00% | New | 72,212 | $1.5M |
| Norges Bank | 0.00% | No change | 70,000 | $1.4M |
| TD Asset Management Inc | 0.00% | Reduce -38.7% | 62,198 | $1.3M |
| State Street Corp. | 0.00% | New | 58,046 | $1.2M |
| Maven Securities LTD | 0.07% | New | 29,930 | $613K |
| Morgan Stanley | 0.00% | New | 24,228 | $496K |
| WINTON GROUP Ltd | 0.03% | New | 24,127 | $494K |
| LMR Partners LLP | 0.01% | Reduce -60.0% | 20,000 | $410K |
| Bank of New York Mellon Corp | 0.00% | New | 19,970 | $409K |
| Bank of America Corp. | 0.00% | New | 19,110 | $391K |
| Acuta Capital Partners, LLC | 0.29% | Reduce -12.0% | 17,600 | $360K |
| Rhumbline Advisers | 0.00% | New | 15,843 | $324K |
| Barclays PLC | 0.00% | Add +36.8% | 12,863 | $263K |
| Citigroup Inc. | 0.00% | New | 12,774 | $262K |
| Nuveen Asset Management, LLC | 0.00% | New | 12,068 | $247K |
| MetLife Investment Management, LLC | 0.00% | New | 5,710 | $117K |
| UBS Group AG | 0.00% | Add +77.7% | 5,557 | $114K |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 0.00% | New | 5,077 | $104K |
| Sandia Investment Management LP | 0.17% | No change | 5,000 | $102K |
| Corebridge Financial, Inc. | 0.00% | New | 4,967 | $102K |
| SG Americas Securities, LLC | 0.00% | New | 4,934 | $101K |
| JPMorgan Chase & Co. | 0.00% | New | 4,033 | $83K |
| Wells Fargo & Company | 0.00% | New | 3,472 | $71K |
| STRS Ohio | 0.00% | New | 1,700 | $35K |
| BNP Paribas Financial Markets | 0.00% | New | 1,684 | $34K |
| Royal Bank of Canada | 0.00% | Add +554.2% | 1,472 | $31K |
| Values First Advisors, Inc. | 0.02% | New | 1,507 | $31K |
| Tidemark, LLC | 0.01% | No change | 1,088 | $22K |
| Ameritas Investment Partners, Inc. | 0.00% | New | 941 | $19K |
| Legal & General Group Plc | 0.00% | New | 909 | $19K |
| California State Teachers Retirement System | 0.00% | New | 685 | $14K |
| Amalgamated Bank | 0.00% | New | 317 | $6K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 257 | $5K |
| Sterling Capital Management LLC | 0.00% | — | 19 | $389 |
"% of holder's portfolio" is RAPP's weight in each manager's 13F, not the share of Rapport Therapeutics Inc. the manager owns.